MSB 2.17% $1.13 mesoblast limited

Cell Therapy News/Articles, page-11624

  1. 6,304 Posts.
    lightbulb Created with Sketch. 373
    Anti-viral drug remdesivir reduces risk of hospitalization by 87%

    Hot off the press.......interesting that remdesivir has been in use for the duration of the pandemic and Gillead has just announced their phase 3 trial results ?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.